-
Notable Analyst Rating Changes 09/14: HOLX, MRX, TOT Upgraded; CPB, XOM, NWL, IPXL Downgraded
-
Daily State of the Markets: Breaking on Through?
-
Color on RBC Upgrade of Medicis (MRX): Cites Recent FDA Approval of 2 Additional Strengths for Solodyn
-
RBC Capital Upgrades Medicis Pharmaceutical (MRX) to Outperform
